Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionBTC Capital Management, Inc.
Latest Disclosed Ownership111,932 shares
Latest Disclosed Value $ 15,595,921
BTC Capital Management, Inc. reports 5.10% decrease in ownership of GILD / Gilead Sciences, Inc.

On April 20, 2026 - BTC Capital Management, Inc. filed a 13F-HR form disclosing ownership of 111,932 shares of Gilead Sciences, Inc. (CH:GILD) valued at $15,595,921 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 15, 2026 disclosing 117,947 shares of Gilead Sciences, Inc.. This represents a change in shares of -5.10% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-20 2026-03-31 13F GILEAD SCIENCES COM 375558103 111,932 -6,015 -5.10 15,596 7.73 0.5532
2026-01-15 2025-12-31 13F GILEAD SCIENCES COM 375558103 117,947 -915 -0.77 14,476 9.74 1.0101
2025-11-06 2025-09-30 13F GILEAD SCIENCES COM 375558103 118,862 64,668 119.33 13,192 122.37 0.9104
2025-07-11 2025-06-30 13F GILEAD SCIENCES COM 375558103 54,194 6,864 14.50 5,933 11.82 0.4843
2025-04-08 2025-03-31 13F GILEAD SCIENCES COM 375558103 47,330 -6,325 -11.79 5,305 7.04 0.4852
2025-01-23 2024-12-31 13F GILEAD SCIENCES COM 375558103 53,655 -17,282 -24.36 4,956 -16.66 0.4594
2024-10-21 2024-09-30 13F GILEAD SCIENCES COM 375558103 70,937 -4,582 -6.07 5,947 14.78 0.5288
2024-07-19 2024-06-30 13F GILEAD SCIENCES COM 375558103 75,519 -1,124 -1.47 5,181 -7.71 0.4810
2024-04-11 2024-03-31 13F GILEAD SCIENCES COM 375558103 76,643 2,951 4.00 5,614 1.67 0.5133
2023-10-17 2023-09-30 13F GILEAD SCIENCES COM 375558103 73,692 -148 -0.20 5,522 -2.30 0.6375
2023-07-11 2023-06-30 13F GILEAD SCIENCES COM 375558103 73,840 1,508 2.08 5,653 -5.04 0.6111
2023-04-07 2023-03-31 13F GILEAD SCIENCES COM 375558103 72,332 -1,881 -2.53 5,953 -6.58 0.6847
2023-01-27 2022-12-31 13F GILEAD SCIENCES COM 375558103 74,213 -8,279 -10.04 6,371 25.27 0.7661
2022-10-17 2022-09-30 13F GILEAD SCIENCES COM 375558103 82,492 9,493 13.00 5,086 12.80 0.6646
2022-08-08 2022-06-30 13F/A-1 GILEAD SCIENCES COM 375558103 72,999 44,044 152.11 4,509 162.00 0.5512
2022-07-25 2022-06-30 13F GILEAD SCIENCES COM 375558103 72,999 44,044 4,509 0.5470
2022-05-06 2022-03-31 13F GILEAD SCIENCES COM 375558103 28,955 -56,791 -66.23 1,721 -72.36 0.1225
2022-05-06 2022-03-31 13F GILEAD SCIENCES COM 375558103 82,351 4,896
2022-02-09 2021-12-31 13F GILEAD SCIENCES COM 375558103 85,746 13,203 18.20 6,227 22.97 0.6155
2021-11-15 2021-09-30 13F GILEAD SCIENCES COM 375558103 72,543 3,871 5.64 5,064 6.59 0.5681
2021-08-02 2021-06-30 13F GILEAD SCIENCES COM 375558103 68,672 -8,807 -11.37 4,751 -5.02 0.5409
2021-05-04 2021-03-31 13F GILEAD SCIENCES COM 375558103 77,479 -383 -0.49 5,002 10.40 0.5585
2021-01-28 2020-12-31 13F GILEAD SCIENCES COM 375558103 77,862 19,263 32.87 4,531 22.36 0.5406
2020-10-14 2020-09-30 13F GILEAD SCIENCES COM 375558103 58,599 4,736 8.79 3,703 -10.64 0.5166
2020-08-04 2020-06-30 13F GILEAD SCIENCES COM 375558103 53,863 2,654 5.18 4,144 8.23 0.6336
2020-05-06 2020-03-31 13F GILEAD SCIENCES COM 375558103 51,209 -2,540 -4.73 3,829 9.74 0.7311
2020-02-13 2019-12-31 13F GILEAD SCIENCES COM 375558103 53,749 -637 -1.17 3,489 1.07 0.4969
2019-10-18 2019-09-30 13F GILEAD SCIENCES COM 375558103 54,386 3,343 6.55 3,452 0.09 0.5510
2019-07-26 2019-06-30 13F GILEAD SCIENCES COM 375558103 51,043 51,043 3,449 0.5581
2016-05-02 2016-03-31 13F GILEAD SCIENCES COM 375558103 0 -2,274 -100.00 0 -100.00
2016-02-08 2015-12-31 13F GILEAD SCIENCES COM 375558103 2,274 -109 -4.57 230 -1.71 0.0538
2015-10-22 2015-09-30 13F GILEAD SCIENCES COM 375558103 2,383 -641 -21.20 234 -33.71 0.0563
2015-08-04 2015-06-30 13F GILEAD SCIENCES COM 375558103 3,024 -29 -0.95 353 18.46 0.0821
2015-05-11 2015-03-31 13F GILEAD SCIENCES COM 375558103 3,053 -160 -4.98 298 -1.32 0.0686
2015-02-11 2014-12-31 13F GILEAD SCIENCES COM 375558103 3,213 -613 -16.02 302 -25.80 0.0748
2015-02-17 2014-09-30 13F/A-1 GILEAD SCIENCES COM 375558103 3,826 3,826 407 0.1031
2014-11-24 2014-09-30 13F GILEAD SCIENCES COM 375558103 3,826 407
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.